
Keywords: Avian infectious bronchitis virus; BR-I genotype; Chitosan nanoparticles; Inactivated vaccine; Mucosal immune responses; AF; allantoic fluid; BPL; beta-propiolactone; CEF; Chicken Embryo Fibroblast; CMI; cell-mediated immune; IB; infectious bronchitis; IB